Who owns the COGNITIDE trademark?

The COGNITIDE trademark is owned by Jaquish Biomedical Corporation.

What class is the COGNITIDE trademark registered in?

The COGNITIDE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for COGNITIDE?

The USPTO serial number for COGNITIDE is 98252892.

What is the registration number for COGNITIDE?

COGNITIDE is registered under USPTO registration number 7875035.

Sealvo

Home Search: COGNITIDECOGNITIDE #98252892

Back

Updated Sep 17, 2026·37 searches this week

View on USPTO TSDR Find similar marks

COG

USPTO Trademark Record

REGISTERED

COGNITIDE

SN 98252892·Reg 7875035·Filed Nov 02, 2023

Owner Jaquish Biomedical Corporation

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

COGNITIDE (Serial No. 98252892), Registration No. 7875035, is a registered US trademark filed on Nov 02, 2023 by Jaquish Biomedical Corporation. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: July 29, 2031

Conflict Analysis

Full conflict analysis for COGNITIDE (SN 98252892) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

COGNITIDE (Reg. #7875035) is a registered US trademark that has been protecting its owner, Jaquish Biomedical Corporation, since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Nov 02, 2023

SERIAL

98252892

REG#

7875035

REGISTERED

Jul 29, 2025

Filing Information

StatusREGISTERED

Filing DateNov 02, 2023

Serial Number98252892

Registration No.7875035

Registration DateJul 29, 2025

Status DateJul 29, 2025

Published for OppositionJul 23, 2024

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1791403

480May 02, 2024

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Feb 19, 2024

First use in commerce: Feb 19, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

19 events

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 07, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 07, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 07, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Jul 29, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 29, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jul 16, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 09, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 29, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

May 29, 2025

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Mar 05, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Mar 04, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Sep 17, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jul 23, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 23, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 03, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 17, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jun 13, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 20, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Nov 06, 2023

NEW APPLICATION ENTERED

Other Marks by Jaquish Biomedical Corporation

Additional USPTO filings from the same owner.

FOR

FORTAGEN

88623787

Jaquish Biomedical Corporation

REGISTERED

INP

IN-PERIUM

88737806

Jaquish Biomedical Corporation

REGISTERED

JAQ

JAQUISH BIOMEDICAL X3

87857946

JAQUISH BIOMEDICAL CORPORATION

REGISTERED

JAQ

JAQUISH BIOMEDICAL X3

87857950

JAQUISH BIOMEDICAL CORPORATION

REGISTERED

Other Marks by Carla B. Oakley

Additional USPTO filings handled by the same attorney of record.

ISO

ISOSAMPLER

97870716

REGISTERED

MET

METALPAY

87792642

REGISTERED

MUL

MULTIPLYLABS

97188511

REGISTERED

SPR

SPRQ

98978380

REGISTERED

COGNITIDE

Run a conflict check

Other Marks by Jaquish Biomedical Corporation

Other Marks by Carla B. Oakley

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company